Progress in Schizophrenia ResearchNova Publishers, 2005 - Всего страниц: 218 Schizophrenia is a chronic, severe, and disabling psychosis, which is an impairment of thinking in which the interpretation of reality is abnormal. Psychosis is a symptom of a disordered brain. Approximately one percent of the population world-wide develops schizophrenia during their lifetime. Although schizophrenia affects men and women with equal frequency, the disorder often appears earlier in men, usually in the late teens or early twenties, than in women, who are generally affected in the twenties to early thirties. People with schizophrenia often suffer symptoms such as hearing internal voices not heard by others, or believing that other people are reading their minds, controlling their thoughts, or plotting to harm them. The current evidence concerning the causes of schizophrenia is a mosaic. It is quite clear that multiple factors are involved. These include changes in the chemistry of the brain, changes in the structure of the brain, and genetic factors. Viral infections and head injuries may also play a role. New molecular tools and modern statistical analyses are allow focusing in on particular genes that might make people more susceptible to schizophrenia by affecting, for example, brain development or neurotransmitter systems governing brain functioning. State-of-the-art imaging techniques are being used to study the living brain. They have recently revealed specific, subtle abnormalities in the structure and function of the brains of patients with schizophrenia. In other imaging studies, early biochemical changes that may precede the onset of disease symptoms have been noted, prompting examination of the neural circuits that are most likely to be involved in producing those symptoms. This new book presents the newest in-depth research from around the world on schizophrenia. |
Содержание
1 | |
23 | |
REALITY MONITORING FAILURE IN SCHIZOPHRENIA RELATION TO CLINICAL SYMPTOMS AND IMPAIRMENT OF SELFCONCEPT | 45 |
PSYCHOTIC DISORDER DUE TO TRAUMATIC BRAIN INJURY REVIEW OF THE LITERATURE | 77 |
LIPID ABNORMALITIES IN SCHIZOPHRENIA AND RELATED DISORDERS | 97 |
RECURRENT CORTICOCORTICAL INTERACTIONS IN NEURAL DISEASE | 119 |
DETERMINANTS OF MEDICATION COMPLIANCE IN SCHIZOPHRENIA | 131 |
LATE LIFE OF SCHIZOPHRENIA TREATMENT CHALLENGES | 149 |
SOCIAL SKILLS TRAINING FOR PEOPLE WITH SCHIZOPHRENIA THEORY PRACTICE AND EVIDENCE | 181 |
INDEX | 209 |
Часто встречающиеся слова и выражения
abnormalities activity antipsychotics areas assessment associated behaviors brain cell changes chronic clinical clozapine cognitive compared compliance consumers cortex cortical deficits delusions demonstrated disease disorder dopamine dose drug effects efficacy elderly patients et al evidence evolutionary example experience experimenter factors fatty acids figure findings function hallucinations hospital human impairment important improvement increase individuals injury interactions involved Journal LCFA learning literature mean measures medication membrane memory mental negative neurons observed olanzapine onset organization outcome patients with schizophrenia performance persons positive potential presented problem processing Psychiatry Psychology psychopathology psychosis psychotic range recent receptors reduced relationship reported Research response risk risperidone role schizophrenic patients selection self-concept severe showed shown significant similar sleep social skills training specific studies subjects suggested symptoms Table temporal theory treatment visual